leaderboard background final minSlide thumbnail
2021 GMP Production available.
Vigene Biosciences offers research-grade and cGMP production of AAV, lentivirus, retrovirus, adenovirus, and plasmid that complies with FDA and EMA guidelines.

Excellence in Viral Vector-based Gene Delivery

AAV Gene Delivery

AAV

For tissue specificity and low immunogenicity in vivo.

AAV Packaging Services >
cGMP AAV Production >

Adenovirus Gene Delivery

Adenovirus

For a large packaging capacity and high transduction efficiency.

Adenovirus Packaging Services >
cGMP Adenovirus Production >

Lentivirus Gene Delivery

Lentivirus

For strong and stable gene expression.

Lentivirus Packaging Services >
cGMP Lentivirus Production >

Popular Services

Sign up for the Vigene Newsletter!

Join over 20,000 scientists who receive monthly updates about Vigene news, product releases, and promotions.
Viral Delivery Guide Revised

Viral Delivery Guide

Not sure which virus to use? Read our Viral Delivery Guide to find out which virus will work best for your specific applications.

Newsroom

October 12, 2020

Vigene Strengthens Management Team Critical Execut...

Vigene Biosciences announces today an executive addition. Molly McGlaughlin is appointed as Chief Operation Officer.
October 9, 2020

Rznomics Announces Manufacturing Agreement with Vi...

Vigene has entered a contract manufacturing agreement with Rznomics Inc. for its leading pipeline product, RZ-001. RZ-001 is a gene therapy for advanced hepatocellular carcinoma (HCC).
August 31, 2020

Vigene Biosciences made the 2020 Inc. 5000 list of...

Vigene Biosciences made the 2020 Inc. 5000 list of the fastest-growing private companies in America!
July 22, 2020

Altimmune Announces Manufacturing Agreement with V...

Vigene entered an agreement with Altimmune to manufacture its single-dose intranasal vaccine candidate for COVID-19.
Partnership Vigene and Virovek colors

Vigene partners with Virovek for cGMP BAC-to-AAV production technology

Virovek has granted Vigene an exclusive cGMP license for their proprietary BAC-to-AAV production technology. AAV vectors generated from this scalable and efficient platform have been proven to infect and transduce a myriad of mammalian cell lines in vitro and a broad range of cell types in vivo.

Read More

Explore Resources

Technical Resources

Get the information you need from our guides and safety data sheets.

Explore Technical Resources >

Citations & Testimonials

Find out how scientists are using our products and services.

Explore Citations & Testimonials >

FAQs

Have a general or technical question? Start here first.

Explore FAQs >

Have questions?

Let’s find the product or service that meets your needs.

Talk to a Scientist